Structure |
Chemical Name |
CAS |
MF |
![Moxifloxacin Impurity 31](/) |
Moxifloxacin Impurity 31 |
|
|
![Pitavastatin Impurity 7](/) |
Pitavastatin Impurity 7 |
|
|
![Prednisolone Impurity A](/CAS/20200119/GIF/77017-17-5.gif) |
Prednisolone Impurity A |
77017-17-5 |
C21H26O5 |
![Rivaroxaban Impurity 61](/CAS/20200515/GIF/1643354-27-1.gif) |
Rivaroxaban Impurity 61 |
1643354-27-1 |
C32H30N4O8 |
![Rivaroxaban Impurity 74](/) |
Rivaroxaban Impurity 74 |
|
|
![Sitafloxacin Impurity 6](/) |
Sitafloxacin Impurity 6 |
|
|
![Ticagrelor Related Compound 75](/) |
Ticagrelor Related Compound 75 |
|
|
![Ticagrelor Related Compound 93](/CAS/20210111/GIF/2207528-55-8.gif) |
Ticagrelor Related Compound 93 |
2207528-55-8 |
C23H28F2N6O4S |
![Vonoprazan Impurity 24](/CAS/20200515/GIF/1807642-41-6.gif) |
Vonoprazan Impurity 24 |
1807642-41-6 |
C16H14FN3O2S |
![Vonoprazan Impurity 35](/) |
Vonoprazan Impurity 35 |
|
|
![Blonanserin Impurity L](/) |
Blonanserin Impurity L |
|
|
![Cefazolin USP Impurity E](/) |
Cefazolin USP Impurity E |
|
|
![Exemestane Impurity 5](/) |
Exemestane Impurity 5 |
|
|
![Medetomidine Impurity 28](/CAS/20200515/GIF/2240179-64-8.gif) |
Medetomidine Impurity 28 |
2240179-64-8 |
C23H28N2 |
![Peramivir Impurity 4](/CAS/20200515/GIF/229615-12-7.gif) |
Peramivir Impurity 4 |
229615-12-7 |
C15H28N4O4 |
![Peramivir Impurity 9](/) |
Peramivir Impurity 9 |
|
|
![PidotimodImpurity T](/) |
PidotimodImpurity T |
|
|
![(Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate](/CAS/20200331/GIF/2093243-16-2.gif) |
(Z)-methyl 3-(hydroxy(phenyl)methylene)-2-oxoindoline-6-carboxylate |
2093243-16-2 |
C17H13NO4 |
![Lenvatinib Impurity 10](/) |
Lenvatinib Impurity 10 |
|
|
![Nifuratel Impurity 10](/) |
Nifuratel Impurity 10 |
|
|
![Ozagrel Impurity 16](/CAS/20200611/GIF/143945-86-2.gif) |
Ozagrel Impurity 16 |
143945-86-2 |
C13H12N2O2 |
![Tofacitinib Impurity 68](/) |
Tofacitinib Impurity 68 |
|
|
![2-(4R,6S)(6-Formyl-2,2-dimethyl-[1,3]dioxan-4-yl)-acetic acid](/CAS/20200119/GIF/123185-91-1.gif) |
2-(4R,6S)(6-Formyl-2,2-dimethyl-[1,3]dioxan-4-yl)-acetic acid |
123185-91-1 |
C9H14O5 |
![5-(3-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3- carbaldehyde](/CAS/20200119/GIF/CB14661208.gif) |
5-(3-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrole-3- carbaldehyde |
|
C16H11FN2O3S |
![Dapoxetine impurity](/CAS/20200515/GIF/126113-24-4.gif) |
Dapoxetine impurity |
126113-24-4 |
C19H16O2 |
![Loratadine Impurity 17](/CAS/20200119/GIF/133330-72-0.gif) |
Loratadine Impurity 17 |
133330-72-0 |
C14H12ClNO |
![Prasugrel Impurity 11](/) |
Prasugrel Impurity 11 |
|
|
![Trelagliptin Impurity 18](/) |
Trelagliptin Impurity 18 |
|
|
![Ropivacaine impurity](/CAS/20200611/GIF/1786560-34-6.gif) |
Ropivacaine impurity |
1786560-34-6 |
C12H14N2O3 |
![N-((3-(5-methyl-3-(4-(N-propionylsulfamoyl)phenyl)isoxazol-4-yl)phenyl)sulfonyl)propionamide](/CAS/20200331/GIF/CB14676620.gif) |
N-((3-(5-methyl-3-(4-(N-propionylsulfamoyl)phenyl)isoxazol-4-yl)phenyl)sulfonyl)propionamide |
|
C22H23N3O7S2 |
![LPHE-009](/CAS/20211123/GIF/64471-45-0.gif) |
LPHE-009 |
64471-45-0 |
C13H16O3 |
![2-((chloro(3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-5- (difluoromethoxy)-1Na-benzo[d]imidazole](/) |
2-((chloro(3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-5- (difluoromethoxy)-1Na-benzo[d]imidazole |
|
|
![(3S,3'S)-3,3'-((((4,4'-dichloro-[1,1'-biphenyl]-3,3'-diyl)bis (methylene))bis(4,1-phenylene))bis(oxy))bis(tetrahydrofuran)](/CAS/20200119/GIF/CB14713877.gif) |
(3S,3'S)-3,3'-((((4,4'-dichloro-[1,1'-biphenyl]-3,3'-diyl)bis (methylene))bis(4,1-phenylene))bis(oxy))bis(tetrahydrofuran) |
|
C34H32Cl2O4 |
![4-(1,3,2-Dioxaborinan-2-yl)benzonitrile](/CAS/20200331/GIF/152846-62-3.gif) |
4-(1,3,2-Dioxaborinan-2-yl)benzonitrile |
152846-62-3 |
C10H10BNO2 |
![Rasagiline Impurity 5 Mesylate](/CAS/20211123/GIF/1312077-04-5.gif) |
Rasagiline Impurity 5 Mesylate |
1312077-04-5 |
C13H15NO4S |
![Ibrutinib Dimer Impurity](/CAS/20200611/GIF/2031255-23-7.gif) |
Ibrutinib Dimer Impurity |
2031255-23-7 |
C50H48N12O4 |
![Rifaximin EP Impurity H](/CAS/20211123/GIF/1210022-90-4.gif) |
Rifaximin EP Impurity H |
1210022-90-4 |
C43H51N3O12 |
![Voriconazole (2R,3R)-Isomer](/CAS/20210111/GIF/137234-76-5.gif) |
Voriconazole (2R,3R)-Isomer |
137234-76-5 |
C16H13ClF3N5O |
![Diquafosol Impurity 12](/CAS/20210111/GIF/694434-51-0.gif) |
Diquafosol Impurity 12 |
694434-51-0 |
C18H26N4O23P4 |
![Etoricoxib Impurity 39](/CAS/20200515/GIF/107825-28-5.gif) |
Etoricoxib Impurity 39 |
107825-28-5 |
C13H17NOS2 |
![Furosemide Impurity 7](/CAS/20200119/GIF/4753-68-8.gif) |
Furosemide Impurity 7 |
4753-68-8 |
C5H8ClNO |
![Irinotecan Impurity 24](/CAS/20210111/GIF/802277-44-7.gif) |
Irinotecan Impurity 24 |
802277-44-7 |
C13H24N2O2 |
![Pyridoxine Impurity 12](/CAS/20200119/GIF/58947-70-9.gif) |
Pyridoxine Impurity 12 |
58947-70-9 |
C8H9NO3 |
![Thiamine](/CAS/20200119/GIF/6309-04-2.gif) |
Thiamine |
6309-04-2 |
C13H20Br2N4OS |
![1,1'-(1,4,8,11-tetraazacyclotetradecane-1,4-diyl)bis(2,2,2- trifluoroethan-1-one) dihydrochloride](/CAS/20200119/GIF/CB14797763.gif) |
1,1'-(1,4,8,11-tetraazacyclotetradecane-1,4-diyl)bis(2,2,2- trifluoroethan-1-one) dihydrochloride |
|
C14H24Cl2F6N4O2 |
![Empagliflozin Impurity 40](/) |
Empagliflozin Impurity 40 |
|
|
![Empagliflozin Impurity 46](/) |
Empagliflozin Impurity 46 |
|
|
![Mupirocin Impurity P/Decyl [2E,8[2S,3S(1S,2S)]]-5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-L-talo-Non-2-enonic Acid Ester](/CAS/20200119/GIF/153900-96-0.gif) |
Mupirocin Impurity P/Decyl [2E,8[2S,3S(1S,2S)]]-5,9-Anhydro-2,3,4,8-tetradeoxy-8-[[3-(2-hydroxy-1-methylpropyl)oxiranyl]methyl]-3-methyl-L-talo-Non-2-enonic Acid Ester |
153900-96-0 |
C27H48O7 |
![pranoprofen](/CAS/20210111/GIF/143436-36-6.gif) |
pranoprofen |
143436-36-6 |
C17H19NO4 |
![2-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]Benzonitrile](/CAS/20200119/GIF/906673-30-1.gif) |
2-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]Benzonitrile |
906673-30-1 |
C14H10BNO3 |
![Fluconazole Impurity 5](/CAS/20200119/GIF/154534-83-5.gif) |
Fluconazole Impurity 5 |
154534-83-5 |
C10H9ClF2N4O |
![Fexofenadine N-Oxide](/CAS/20210111/GIF/1422515-52-3.gif) |
Fexofenadine N-Oxide |
1422515-52-3 |
C32H39NO5 |
![Trimetazidine Impurity 16](/CAS/20200611/GIF/118709-62-9.gif) |
Trimetazidine Impurity 16 |
118709-62-9 |
C13H16O4 |
![Ortho-Isomer of Dapagliflozin](/CAS/20210111/GIF/2040305-05-1.gif) |
Ortho-Isomer of Dapagliflozin |
2040305-05-1 |
C21H25ClO6 |
![Imidafenacin Related Compound 9](/CAS/20211123/GIF/170105-17-6.gif) |
Imidafenacin Related Compound 9 |
170105-17-6 |
C21H21N3 |
![Cefminox Sodium impurity 1](/) |
Cefminox Sodium impurity 1 |
|
|
![Dapagliflozin Impurity 5](/) |
Dapagliflozin Impurity 5 |
|
|
![Emtricitabine Impurity E](/) |
Emtricitabine Impurity E |
|
|
![Furosemide Impurity 4](/CAS/20200331/GIF/CB14812970.gif) |
Furosemide Impurity 4 |
|
C12H11ClN2O5S |
![Pitavastatin Impurity 43](/) |
Pitavastatin Impurity 43 |
|
|
![1-((2R,3R)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-(((3-(hydroxymethyl)pyridin-2-yl)(methyl)carbamoyl)oxy)ethyl)-1H-1,2,4-triazol-4-ium chloride](/) |
1-((2R,3R)-3-(4-(4-cyanophenyl)thiazol-2-yl)-2-(2,5-difluorophenyl)-2-hydroxybutyl)-4-(1-(((3-(hydroxymethyl)pyridin-2-yl)(methyl)carbamoyl)oxy)ethyl)-1H-1,2,4-triazol-4-ium chloride |
|
|
![1H-1,2,4-Triazole-1-propanol, α-(2,4-difluorophenyl)-α-(1H-1,2,4-triazol-1-ylmethyl)-](/CAS/20211123/GIF/1222655-38-0.gif) |
1H-1,2,4-Triazole-1-propanol, α-(2,4-difluorophenyl)-α-(1H-1,2,4-triazol-1-ylmethyl)- |
1222655-38-0 |
C14H14F2N6O |
![3-Pyrrolidinepropanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-, (αS,3S)-](/CAS/20211123/GIF/741267-75-4.gif) |
3-Pyrrolidinepropanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-, (αS,3S)- |
741267-75-4 |
C12H20N2O5 |
![Topiroxostat Impurity 44](/CAS/20211123/GIF/1824131-48-7.gif) |
Topiroxostat Impurity 44 |
1824131-48-7 |
C7H6N4O |
![Fexofenadine Impurity 12](/CAS/20210305/GIF/1010812-98-2.gif) |
Fexofenadine Impurity 12 |
1010812-98-2 |
C32H37NO4 |
![2,2'-(oxybis((2-chloro-5-iodophenyl)methylene))diphenol](/CAS/20181212/GIF/CB38117749.gif) |
2,2'-(oxybis((2-chloro-5-iodophenyl)methylene))diphenol |
|
C26H18Cl2I2O3 |
![Gliclazide Impurity 6](/CAS/20210111/GIF/1207714-41-7.gif) |
Gliclazide Impurity 6 |
1207714-41-7 |
C8H10N2O3S |
![Phenol, 4,4'-(4-pyridinylmethylene)bis-](/CAS/20210111/GIF/109810-81-3.gif) |
Phenol, 4,4'-(4-pyridinylmethylene)bis- |
109810-81-3 |
C18H15NO2 |
![Ropivacaine Impurity 50](/) |
Ropivacaine Impurity 50 |
|
|
![Glycine, N-[(4,7-dihydroxy-1-methyl-3-isoquinolinyl)carbonyl]-](/CAS/20210111/GIF/2173338-12-8.gif) |
Glycine, N-[(4,7-dihydroxy-1-methyl-3-isoquinolinyl)carbonyl]- |
2173338-12-8 |
C13H12N2O5 |
![5-Thiazolecarboxylic acid, 2-[3,5-diformyl-4-(2-methylpropoxy)phenyl]-4-methyl-, ethyl ester](/CAS/20200611/GIF/2375033-26-2.gif) |
5-Thiazolecarboxylic acid, 2-[3,5-diformyl-4-(2-methylpropoxy)phenyl]-4-methyl-, ethyl ester |
2375033-26-2 |
C19H21NO5S |
![Furosemide Impurity 6](/CAS/20210111/GIF/74793-12-7.gif) |
Furosemide Impurity 6 |
74793-12-7 |
C12H10ClNO3 |
![Lumateperone Impurity 3](/CAS/20210111/GIF/313544-76-2.gif) |
Lumateperone Impurity 3 |
313544-76-2 |
C17H21N3O3 |
![Butanoic acid, L-2-aminobutanoyl-L-2-amino-, methyl ester (9CI)](/CAS/20210305/GIF/772292-30-5.gif) |
Butanoic acid, L-2-aminobutanoyl-L-2-amino-, methyl ester (9CI) |
772292-30-5 |
C9H18N2O3 |
![Hexanoic acid, 3-(hydroxymethyl)-, (3R)-](/CAS/20210111/GIF/2096999-79-8.gif) |
Hexanoic acid, 3-(hydroxymethyl)-, (3R)- |
2096999-79-8 |
C7H14O3 |
![2-(((Z)-(1-(2-aminothiazol-4-yl)-2-(((2S,3S)-1-(ethoxysulfonyl)-2-methyl-4-oxoazetidin-3-yl)amino)-2-oxoethylidene)amino)oxy)-2-methylpropanoic acid](/) |
2-(((Z)-(1-(2-aminothiazol-4-yl)-2-(((2S,3S)-1-(ethoxysulfonyl)-2-methyl-4-oxoazetidin-3-yl)amino)-2-oxoethylidene)amino)oxy)-2-methylpropanoic acid |
|
|
![3-Thiophenecarboxylic acid, 4-formyl-2,5-dihydro-2-(4-hydroxybutylidene)-5-methyl-, (2Z)-](/CAS/20210111/GIF/1025974-23-5.gif) |
3-Thiophenecarboxylic acid, 4-formyl-2,5-dihydro-2-(4-hydroxybutylidene)-5-methyl-, (2Z)- |
1025974-23-5 |
C11H14O4S |
![1H-Pyrrole-3-methanamine, 1-[(1,4-dihydro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)-N-methyl-](/CAS/20200611/GIF/2416241-98-8.gif) |
1H-Pyrrole-3-methanamine, 1-[(1,4-dihydro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)-N-methyl- |
2416241-98-8 |
C17H18FN3O2S |
![impurity 44](/) |
impurity 44 |
|
|
![3-((2-acetamido-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)propane- 1,2-diyl diacetate](/) |
3-((2-acetamido-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)propane- 1,2-diyl diacetate |
96429-68-4 |
|
![L-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, γ-lactone, 3,5-dibenzoate, (2S)-](/CAS/20210305/GIF/1946820-91-2.gif) |
L-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, γ-lactone, 3,5-dibenzoate, (2S)- |
1946820-91-2 |
C20H17FO6 |
![5,5'-Bi-1H-benzimidazole, 6,6'-bis(difluoromethoxy)-2,2'-bis[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]-](/CAS/20200611/GIF/2251784-93-5.gif) |
5,5'-Bi-1H-benzimidazole, 6,6'-bis(difluoromethoxy)-2,2'-bis[[(3,4-dimethoxy-2-pyridinyl)methyl]thio]- |
2251784-93-5 |
C32H28F4N6O6S2 |
![1,4,7,10-Tetraazacyclododecane-1,7-diacetic acid, 4,10-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]-](/CAS/20200611/GIF/2514736-58-2.gif) |
1,4,7,10-Tetraazacyclododecane-1,7-diacetic acid, 4,10-bis[2,3-dihydroxy-1-(hydroxymethyl)propyl]- |
2514736-58-2 |
C20H40N4O10 |
![Valsartan Methyl Ester N2-Trityl Analog](/CAS/20200611/GIF/883223-10-7.gif) |
Valsartan Methyl Ester N2-Trityl Analog |
883223-10-7 |
C44H45N5O3 |
![Ampicillin Impurity G](/) |
Ampicillin Impurity G |
|
|
![N-(5-((diphenylphosphoryl)methyl)-4-(3-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide](/) |
N-(5-((diphenylphosphoryl)methyl)-4-(3-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide |
|
|
![Budesonide Impurity 28](/) |
Budesonide Impurity 28 |
|
|
![Ethanol, 2-[2-(2-methyl-4-nitro-1H-imidazol-1-yl)ethoxy]-](/CAS/20210111/GIF/19765-12-9.gif) |
Ethanol, 2-[2-(2-methyl-4-nitro-1H-imidazol-1-yl)ethoxy]- |
19765-12-9 |
C8H13N3O4 |
![INDEX NAME NOT YET ASSIGNED](/CAS/20211123/GIF/2452301-30-1.gif) |
INDEX NAME NOT YET ASSIGNED |
2452301-30-1 |
C23H27ClO7 |
![(5R,6S)-6-((R)-1-hydroxyethyl)-7-oxo-3-((S)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4,4-dioxide](/) |
(5R,6S)-6-((R)-1-hydroxyethyl)-7-oxo-3-((S)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4,4-dioxide |
|
|
![(3S,5R,6E) Rosuvastatin Calcium Salt (2:1)](/CAS/20210111/GIF/2414245-11-5.gif) |
(3S,5R,6E) Rosuvastatin Calcium Salt (2:1) |
2414245-11-5 |
C22H30CaFN3O6S |
![INDEX NAME NOT YET ASSIGNED](/CAS/20211123/GIF/2452301-42-5.gif) |
INDEX NAME NOT YET ASSIGNED |
2452301-42-5 |
C23H27ClO7 |
![2-Amino-2'-fluorbenzophenon](/CAS/GIF/1581-13-1.gif) |
2-Amino-2'-fluorbenzophenon |
1581-13-1 |
C13H10FNO |
![(R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium](/CAS/20210111/GIF/2480467-84-1.gif) |
(R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium |
2480467-84-1 |
C28H35NO7S |
![4-METHYL-6-PYRIDIN-3-YLPYRIMIDIN-2-AMINE](/CAS/GIF/90916-52-2.gif) |
4-METHYL-6-PYRIDIN-3-YLPYRIMIDIN-2-AMINE |
90916-52-2 |
C10H10N4 |
![1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2-ylindenemethyl)piperidine](/CAS/GIF/120014-07-5.gif) |
1-Benzyl-4-(5,6-dimethoxy-1-oxoindan-2-ylindenemethyl)piperidine |
120014-07-5 |
C24H27NO3 |
![Crisaborole Impurity 16](/CAS/20211123/GIF/2268785-42-6.gif) |
Crisaborole Impurity 16 |
2268785-42-6 |
C14H10BNO3 |
![guanidine](/CAS/GIF/113-00-8.gif) |
guanidine |
113-00-8 |
CH5N3 |
![tert-Butyl (E)-3,5-Dihydroxy-7-[3'-(4](/CAS/GIF/194934-96-8.gif) |
tert-Butyl (E)-3,5-Dihydroxy-7-[3'-(4"-fluorophenyl)-1'-methylethylindol-2'-yl)hept-6-enoate |
194934-96-8 |
C28H34FNO4 |
![Brivaracetam Impurity 55](/) |
Brivaracetam Impurity 55 |
|
|